Determination of Calycosin-7-O-Beta-D-Glucopyranoside in Rat Plasma and Urine by Hplc

Guan Ye,Rong-Rong Ma,Zhi-Xiong Li,Hui Wang,Hai-Yan Zhu,Zhao-Lin Sun,Cheng-Gang Huang
DOI: https://doi.org/10.1002/bmc.819
2007-01-01
Biomedical Chromatography
Abstract:A reversed-phase high-performance liquid chromatographic (HPLC) assay for calycosin-7-O-beta-D-glucopyranoside in rat plasma and urine with solid-phase extraction (SPE) was developed. Rutin was employed as an internal standard. The mobile phase consisted of acetonitrile-water (16:84, v/v) at a flow rate of 1.0 mL/min. Detection was set at 280 rim. The limit of quantitation of calycosin-7-O-beta-D-glucopyranoside was 0.2 mu g/mL in both plasma and urine. The standard curve was linear from 0.2 to 10.0 mu g/mL in plasma, and 0.2 to 5.0 mu g/mL in urine. Both intra- and inter-day precision of the calycosin-7-O-beta-D-glucopyranoside were determined and their RSD did not exceed 10%. The method was successfully applied to the analysis of samples obtained from a basic pharmacokinetic study, in which calycosin-7-O-beta-D-glucopyranoside was administered orally to rats. Copyright (c) 2007 John Wiley & Sons, Ltd.
What problem does this paper attempt to address?